Thyrotoxicosis: What is the Cause in Our Population?

Causes of Thyrotoxicosis

Authors

  • Ashfaq Ali Department of Diabetes, College of Family Medicine, Karachi, Pakistan
  • Sulaiman Khan Department of Diabetes, College of Family Medicine, Karachi, Pakistan
  • . Anees Department of Diabetes, College of Family Medicine, Karachi, Pakistan
  • Tariq Hassan Department of Diabetes, College of Family Medicine, Karachi, Pakistan
  • Farah Mufti Department of Diabetes, College of Family Medicine, Karachi, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v6i1.2028

Keywords:

Thyrotoxicosis, Graves' Disease, Toxic Adenoma, Toxic Multinodular Goiter, Endocrinology

Abstract

Thyrotoxicosis is an endocrine disorder in which excess amount of thyroid hormone is secreted in the blood stream and causes its action at the tissue level. Thyrotoxicosis highly affects the quality of life of patients suffering from the disease in carrying out daily activities. Proper treatment of thyrotoxicosis requires an accurate diagnosis. Objective: To determine the causes of thyrotoxicosis in patients reported for evaluation and management to specialized endocrine unit. Methods: This was a descriptive cross sectional observational study conducted by convenient sampling in Outpatient Department (Endocrinology Clinic) Khyber Pakhtunkhwa in six month’s duration (15th December 2023 to 15th May 2024) having sample size n=118. Thyrotoxicosis was labeled if patient has high T3, T4 (thyroxine and/or triiodothyronine) levels and suppressed thyroid stimulating hormones TSH levels. Information was gathered from the patients regarding their clinical signs and symptoms and anthropometrics. Laboratory investigations of thyroid function tests were obtained and analyzed. Results: The mean age of 118 patients was 40.39 ± 13.69 years, 28% male and 72% female patients were in enrolled in the study. Graves’ disease was most common form thyrotoxicosis making count of 50% of patients followed by toxic adenoma, toxic MNG, thyroiditis 16% and 14 % respectively. Anti-thyroid drugs count 43% of most of the patient’s treatment offered followed by radioactive iodine 28%. Conclusions: In conclusion, the main cause of thyrotoxicosis, includes grave’s disease, toxic adenoma and toxic MNG in Pakistani population. Thyrotoxicosis was more prevalent among female population as compared to males.

References

Anandkumar S, Chacko J, Usha M. Thyroid disorder: An overview. Research Journal of Pharmacology and Pharmacodynamics. 2020; 12(1): 1-4. doi: 10.5958/2321-5836.2020.00001.4.

San Yap P, Ali O, Truran P, Aspinall S. Thyrotoxicosis and thyroiditis. Surgery (Oxford). 2024 Mar; 42(4): 239-245. doi: 10.1016/j.mpsur.2023.10.006.

Muñoz-Ortiz J, Sierra-Cote MC, Zapata-Bravo E, Valenzuela-Vallejo L, Marin-Noriega MA, Uribe-Reina P et al. Prevalence of hyperthyroidism, hypothyroidism, and euthyroidism in thyroid eye disease: a systematic review of the literature. Systematic Reviews. 2020 Dec; 9: 1-2. doi: 10.1186/s13643-020-01459-7.

Bakar RZ, Cetin C, Yozgat CY, Kütük MS. The Effects of Maternal Smoking on Thyroid Function: Findings from Routine First-Trimester Sonographic Anomaly Screening. Zeitschrift für Geburtshilfe und Neonatologie. 2023 Dec;227(06):429-33 doi: 10.1055/a-2165-8262.

Klubo-Gwiezdzinska J and Wartofsky L. Hashimoto thyroiditis: an evidence-based guide to etiology, diagnosis and treatment. Polish Archives of Internal Medicine. 2022 Mar; 132(3). doi: 10.20452/pamw.16222.

American Thyroid Association and American Association of Clinical Endocrinologists Taskforce on Hyperthyroidism and Other Causes of Thyrotoxicosis, Bahn, R.S., Burch, H.B., Cooper, D.S., Garber, J.R., Greenlee, M.C., Klein, I., Laurberg, P., McDougall, I.R., Montori, V.M. and Rivkees, S.A., 2011. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid, 21(6), pp.593-646 doi: 10.1089/thy.2010.0417.

Pearce EN. Diagnosis and management of thyrotoxicosis. Bmj. 2006 Jun 8;332(7554):1369 doi: 10.1136/bmj.332.7554.1369.

Toro-Tobon D, Stan MN. Graves’ disease and the manifestations of thyrotoxicosis. InEndotext [Internet] 2024 Sep 24. MDText. com, Inc.

Mansourian AR. A review on hyperthyroidism: thyrotoxicosis under surveillance. Pakistan Journal of Biological Sciences: PJBS. 2010 Nov 1;13(22):1066-76 doi: https://doi.org/10.3923/pjbs.2010.1066.1076 .

Petranović Ovčariček P, Verburg FA, Hoffmann M, Iakovou I, Mihailovic J, Vrachimis A et al. Higher thyroid hormone levels and cancer. European Journal of Nuclear Medicine and Molecular Imaging. 2021 Mar; 48: 808-21. doi: 10.1007/s00259-020-05018-z.

Kitahara CM and Schneider AB. Epidemiology of thyroid cancer. Cancer Epidemiology, Biomarkers & Prevention. 2022 Jul; 31(7): 1284-97. doi: 10.1158/1055-9965.EPI-21-1440.

Alam¹ Z, Shah M, Khan M, Ali W, Shehzad A, Shah JA, Shahana H, Ahmad A, Jalil¹ F. Thyroid Dysfunction and Prevalence of both clinical and subclinical form of Hyperthyroidism and Hypothyroidism in District Mardan, KPK, Pakistan. KPK, Pakistan. 2019 Oct 11;8:98-104.

Onyenekwe BM. Thyrotoxicosis, etiology, presentation and management challenges in Nigeria: a review of cases seen over a 5 year period. European Scientific Journal European Scientific Journal. 2019 Aug; 15(24): 144-. doi: 10.19044/esj.2019.v15n24p144.

Moleti M, Aversa T, Crisafulli S, Trifirò G, Corica D, Pepe G et al. Global incidence and prevalence of differentiated thyroid cancer in childhood: systematic review and meta-analysis. Frontiers in Endocrinology. 2023 Sep; 14: 1270518. doi: 10.3389/fendo.2023.1270518.

LeClair K, Bell KJ, Furuya-Kanamori L, Doi SA, Francis DO, Davies L. Evaluation of gender inequity in thyroid cancer diagnosis: differences by sex in US thyroid cancer incidence compared with a meta-analysis of subclinical thyroid cancer rates at autopsy. Journal of the American Medical Association Jinternal Medicine. 2021 Oct; 181(10): 1351-8. doi: 10.1001/jamainternmed.2021.4804.

Sahin M, Haymana C, Demirci I, Tasci I, Rıfat E, Unluturk U et al. The clinical outcomes of COVID‐19 infection in patients with a history of thyroid cancer: a nationwide study. Clinical Endocrinology. 2021 Oct; 95(4): 628-37. doi: 10.1111/cen.14486.

Ezber R, Ülgen ED, Ateş İ, Yilmaz N. Evaluation of the Prevalence and Laboratory Test Results of Overt Thyrotoxicosis Cases. Romanian Journal of Internal Medicine. 2024 Mar. doi: 10.2478/rjim-2024-0007.

Hanley P, Lord K, Bauer AJ. Thyroid disorders in children and adolescents: a review. Journal of the American Medical Association Pediatrics. 2016 Oct; 170(10): 1008-19. doi: 10.1001/jamapediatrics.2016.0486.

Pedersen IB, Knudsen N, Perrild H, Ovesen L, Laurberg P. TSH‐receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays. Clinical Endocrinology. 2001 Sep;55(3):381-90 doi: 10.1046/j.1365-2265.2001. 01347.x.

Nabi M, Noor R, Zahid A, Zulfiqar T, Khalid A, Ri S. Grave's Disease: Pathophysiology of a Model Autoimmune Disease. Archives of Microbiology & Immunology. 2022 Mar; 6(2): 149-64. doi: 10.26502/ami.93650083.

Angell TE, Kim MI, Bernet VJ. Thyroiditis. In: Surgery of the thyroid and parathyroid glands. Elsevier; 2021 Jan. p. 40–9. doi: 10.1016/B978-0-323-66127-0.00004-1.

Bhat JA, Patto SM, Sharma P, Bhat MH, Mir SA. Therapeutic options in Graves' hyperthyroidism. In: Hyperthyroidism-recent updates. IntechOpen; 2022. doi: 10.5772/intechopen.106562.

Downloads

Published

2025-01-31
CITATION
DOI: 10.54393/pjhs.v6i1.2028
Published: 2025-01-31

How to Cite

Ali, A., Khan, S., Anees, ., Hassan, T., & Mufti, F. (2025). Thyrotoxicosis: What is the Cause in Our Population? Causes of Thyrotoxicosis. Pakistan Journal of Health Sciences, 6(1), 12–16. https://doi.org/10.54393/pjhs.v6i1.2028

Issue

Section

Original Article

Plaudit